JILL BLANCHARD: Open Payments
NPI 1619712304 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,391 in 77 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $94 · 2025 $1,391
Food & beverage: $1,391
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $225 |
| Kowa Pharmaceuticals America, Inc. | 9 | $188 |
| PFIZER INC. | 12 | $176 |
| Xeris Pharmaceuticals, Inc. | 5 | $99 |
| Novo Nordisk Inc | 5 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| Lilly USA, LLC | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Exact Sciences Corporation | 3 | $52 |
Products named: ZORYVE, NURTEC ODT, VRAYLAR, GVOKE HYPOPEN, REXULTI, MOUNJARO, QULIPTA, INGREZZA.
Industry payments across IN — which companies pay providers there.
